Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

Clinical trial NCT03353831 · COMPLETED

Trial details

NCT number: NCT03353831
Sponsor: AGO Research GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Ovarian Carcinoma

Start date: 2018-09-11
Primary completion: 2025-03-11
Enrollment: 574

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.